Last update 21 Nov 2024

EP-2101

Overview

Basic Info

Drug Type
Shared antigen vaccine, Therapeutic vaccine
Synonyms
Tedopi
+ [2]
Target
Mechanism
p53 modulators(Tumor protein p53 modulators), Immunostimulants
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerPhase 3--
Advanced Lung Non-Small Cell CarcinomaPhase 2
HU
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
ES
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
IT
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
FR
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
US
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
IL
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
GB
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
PL
12 Feb 2016
Advanced Lung Non-Small Cell CarcinomaPhase 2
CZ
12 Feb 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
(oldypivrzd): HR = 0.86 (95% CI, 0.62 - 1.19), P-Value = 0.36
Positive
01 Oct 2023
Phase 3
Non-Small Cell Lung Cancer
EGFR negative | ALK negative
118
(PS ≤1)
(arlzgbaiil) = avemxkxyeh lqakzvparf (hghmdoikym, 11.1 - 16.8)
Positive
31 May 2023
(PS deteriorated > 1)
(arlzgbaiil) = aevekpupwk lqakzvparf (hghmdoikym, 2.9 - 8.2)
Phase 3
219
fftyaxafzf(oggtunoyss) = gvdqwxqahz qgnuihxuxb (qahkhwregt )
Positive
10 Sep 2022
Phase 3
118
(simfomcsjn) = zdtokwylre rhgntactfq (ojsltgtewd )
Positive
10 Sep 2022
Phase 3
95
(hmubirtxti) = dczbyzfuwq cecqzazvyj (qmxwwnfwyn )
Positive
02 Jun 2022
(hmubirtxti) = aoyifekddv cecqzazvyj (qmxwwnfwyn )
Phase 2
29
(ydbbnnldos) = vwufzskvuz eaomwkcvhr (qfdfkpsoid, 12.3 - 67.0)
Non-superior
02 Jun 2022
(ydbbnnldos) = deshjkbzml eaomwkcvhr (qfdfkpsoid, 7.1 - 57.8)
Phase 3
219
(nssnjalmxi) = wexvonqhgl zqsdhppcjq (lvfznsebka )
Positive
20 Sep 2021
(nssnjalmxi) = wiudqbxvke zqsdhppcjq (lvfznsebka )
Phase 3
99
ogdiycwihf(jnrjzalyzq) = dplcwvoyha bonizhrgcm (zvaexyswzv, 33 - 59)
Positive
18 Sep 2020
ogdiycwihf(jnrjzalyzq) = owvutatkqz bonizhrgcm (zvaexyswzv, 21 - 54)
Phase 2
68
(yjcgiyuylr) = nlqhfcndqt bjvtloqbgi (xuoavpuzbh )
-
20 May 2008
Phase 2
66
cotgbmajwa(wxbpyqldpd) = gqmfznuoxl qzqngvksrn (koikgszpor )
-
20 Jun 2007
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free